INOVIA is indicated in adults for the treatment of type 2 diabetes mellitus insufficiently controlled, as an adjunct to diet and physical exercise:
As monotherapy when metformin is considered inappropriate due to intolerance.
In combination with other medicinal products used in the treatment of type 2 diabetes mellitus.
Heart Failure
INOVIA is indicated in adults for the treatment of symptomatic chronic heart failure.
Chronic Kidney Disease
INOVIA is indicated in adults for the treatment of chronic kidney disease.
| Specialty | INOVIA |
|---|---|
| Dosage | 5 mg |
| Form | Film-coated tablet |
| Presentation | B/90 |
| Active ingredient (INN) | DAPAGLIFLOZIN PROPRANEDIOL |
| Laboratory | PHILADELPHIA PHARMA |
| Therapeutic class | DIGESTIVE SYSTEM AND METABOLISM |
| Subclass | MEDICINE USED IN THE TREATMENT OF DIABETES |
| Packaging | Blister |
| Specification | ALU/ALU |
| List | A |
| Shelf life | 24 months |
Reviews
There are no reviews yet.